ArticleBMJ open2024

Etrolizumab as induction and maintenance therapy in patients with moderately to severely active ulcerative colitis: a protocol of systematic review and meta-analysis of placebo-controlled, randomised clinical trials.

Xuan Qin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.